• Connect with us
    • Information
      • About Us
      • Contact Us
      • Careers
      • Partnerships
      • Advertise With Us
      • Authors
      • Browse Topics
      • Events
      • Disclaimer
      • Privacy Policy
    • NORTH AMERICA EDITION
      Australia
      North America
      World
    Login
    Investing News NetworkYour trusted source for investing success
    • NORTH AMERICA EDITION
      North America
      Australia
      World
    • My INN
    Videos
    Companies
    Press Releases
    Private Placements
    SUBSCRIBE
    • Reports & Guides
      • Market Outlook Reports
      • Investing Guides
    • Button
    Resource
    • Precious Metals
    • Battery Metals
    • Base Metals
    • Energy
    • Critical Metals
    Tech
    Life Science
    Life Science Market
    Life Science News
    Life Science Stocks
    • Life Science Market
    • Life Science News
    • Life Science Stocks
    life science investing

    Canadian Ebola Vaccine to Undergo Testing in West Africa

    Charlotte McLeod
    Mar. 05, 2015 04:04PM PST
    Life Science Investing News

    The Canadian Press reported that an Ebola vaccine developed in a lab in Winnipeg is set to be tested in three studies in West Africa.

    The Canadian Press reported that an Ebola vaccine developed in a lab in Winnipeg is set to be tested in three studies in West Africa.

    As quoted in the market news:

    The World Health Organization and several partners announced Thursday they will start testing the vaccine in Guinea in a trial designed to prove whether it is effective. The trial will begin Saturday.

    Later this month, the U.S. Centers for Disease Control expects to launch a trial of the vaccine — now licensed to biotech company NewLink Genetics and pharmaceutical giant Merck — in Sierra Leone.

    In Liberia, the U.S. National Institutes of Health has begun to test two experimental Ebola vaccines against a placebo in a large randomized controlled trial. The Liberian trial is studying the NewLink-Merck vaccine as well as one designed at the NIH that is being developed by GSK.

    Though that might sound promising, challenges remain:

    These important studies are commencing several months later than had been hoped, past the peak of the West African outbreak. That could make answering the question — Do either or both of these vaccines work? — difficult. Yet people who have been pushing for the development of Ebola vaccines think the work remains critical.

    ‘Testing investigational medicines during an epidemic is incredibly challenging, but this approach gives us the best possible chance of finding a safe and effective vaccine in time to save lives during the current epidemic, and to help us prepare for future outbreaks,’ said Dr. Jeremy Farrah, director of Britain’s Wellcome Trust, which is providing funding for the Guinea trial.

    Click here to read the full report from The Canadian Press.

    life science investing
    The Conversation (0)

    Go Deeper

    AI Powered
    Two vials labelled "H5N1 Vaccine." One stands and one lays on its side behind the first.

    Bird Flu Vaccine Stocks: 8 Companies Developing H5N1 Vaccines

    Global Vaccine Market Experiencing Substantial Growth

    Latest News

    Seegnal Inc. Announces Extension of Maccabi Health Services Contract

    Phase 2 HER2 Clinical Trial Manufacturing Commenced, WSU Imaging Optimisation Program Underway

    More News

    Outlook Reports

    Resource
    • Precious Metals
      • Gold
      • Silver
    • Battery Metals
      • Lithium
      • Cobalt
      • Graphite
    • Energy
      • Uranium
      • Oil and Gas
    • Base Metals
      • Copper
      • Nickel
      • Zinc
    • Critical Metals
      • Rare Earths
    • Industrial Metals
    • Agriculture
    Tech
      • Artificial Intelligence
      • Cybersecurity
      • Gaming
      • Cleantech
      • Emerging Tech
    Life Science
      • Biotech
      • Cannabis
      • Psychedelics
      • Pharmaceuticals

    Featured Life Science Investing News Stocks

    More featured stocks

    Browse Companies

    Resource
    • Precious Metals
    • Battery Metals
    • Energy
    • Base Metals
    • Critical Metals
    Tech
    Life Science
    MARKETS
    COMMODITIES
    CURRENCIES
    ×